FDA Issues Warning Letter to Natuzen
May 15, 2024
May 15, 2024
WASHINGTON, May 15 -- The U.S. Department of Health and Human Services' Food and Drug Administration issued the following warning letter to Natuzen Co. Ltd.:
* * *
To: Mr. Seunghyun Cho, General Manager, Natuzen Co., Ltd., 289 Namdongdong-Ro Namdong-gu, Incheon 21639, South Korea
Dear Mr. Cho:
Your facility is registered with the United States Food and Drug Administration (FDA) as a manufacturer of over-the-counter (OTC) drug products. FDA has . . .
* * *
To: Mr. Seunghyun Cho, General Manager, Natuzen Co., Ltd., 289 Namdongdong-Ro Namdong-gu, Incheon 21639, South Korea
Dear Mr. Cho:
Your facility is registered with the United States Food and Drug Administration (FDA) as a manufacturer of over-the-counter (OTC) drug products. FDA has . . .